ÀÓµµ¼± ¸íÀÇ

º´¿øÀÇ 60ºÐ³» ÀÀ±ÞÁø·á½Ã½ºÅÛÀ» ±¸Ãà

ÀÓµµ¼± ¸íÀÇ

  • ¼Ò ¼Ó
    °í·Á´ëÇб³ ¾È¾Ïº´¿ø ¼øÈ¯±â³»°ú
  • Àü¹®ºÐ¾ß
    Çù½ÉÁõ, ½ÉÇ÷°üÁßÀç¼ú

°í´ë¾È¾Ïº´¿ø ÈäÅëŬ¸®´ÐÀº ±Þ¼º ½É±Ù°æ»öÁõ ȯÀÚ µµÂø ÈÄ 60ºÐ À̳»¿¡ Ä¡·áÇÒ ¼ö ÀÖ´Â ÀÀ±ÞÁø·á ½Ã½ºÅÛÀ» ±¸ÃàÇß´Ù.
ÀÌ Á߽ɿ¡ ÀÓ ±³¼ö°¡ ÀÖ´Ù. ÀÓ ±³¼ö´Â ½ÉÀå°Ç°­À» ÁöŰ´Â ¹æ¹ýÀº ´Ù¸¥ »ç¶÷À» ¹Ý¸é±³»ç(ÚãØüÎçÞÔ)·Î »ï´Â °ÍÀÌ °¡Àå È¿°úÀûÀ̶ó°í »ý°¢ÇÑ´Ù. ȯÀÚ ¼ö±â¸¦ ¿«Àº Ã¥ '½ÉÀå¿¡°Ô ¸» °É±â', ȯÀÚ »ç·Ê¸¦ ±âÃÊ·Î ¸¸µç ¸¸È­ '°¡½¿ÀÌ ¾ÆÆÄ¿ä', °Ç°­ ½Ä»ýȰÀ» °­Á¶ÇÑ ¿ä¸®Ã¥ '3Àú¹ä»ó' µîÀ» ÁýÇÊÇÑ ÀÌÀ¯À̱⵵ ÇÏ´Ù.

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • °í·Á´ëÇб³ ´ëÇпø ¹Ú»ç, ¼øÈ¯±â³»°úÇÐ
  • °í·Á´ëÇб³ ´ëÇпø ¼®»ç, ³»°úÇÐ
  • °í·Á´ëÇб³ Àǰú´ëÇÐ Á¹¾÷

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °í´ë¾È¾Ïº´¿ø ¼øÈ¯±â³»°ú ±³¼ö

¼ö»ó³»¿ª

Awards List
  • °í·Á´ëÇб³ °íÀÇÀÇÇлó (2018)
  • °í·Á´ëÇб³ ¼®Å¾°­ÀÇ»ó (2017)
  • °í·Á´ëÇб³ ¼®Å¾¿¬±¸»ó ¼ö»ó (2017)
  • º¸°Çº¹ÁöºÎ Àå°üǥâ (2011)
  • ¹Ì±¹±¹Á¦ÀθíÁ¤º¸±â°ü(ABI,American Biographical Institute) ¡ºUniversal Award of Accomplishment ¡» µîÀç (2010)
  • °í´ë¾È¾Ïº´¿øÀ» ºû³½ Àι° ¼±Á¤(2010)
  • ¹Ì±¹ ¸¶¸£ÄûÁî ÈÄÁîÈÄ(Marquis Who's Who) ¡ºMarquis Who's Who in the World 2010¡» µîÀç (2009)
  • °¡»ó½Å¾à°³¹ß ¿¬±¸Áø ¼±Á¤. ¾Æ½ºÆ®¶óÁ¦³×Ä«, Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø (2009)
  • ´ëÇѼøÈ¯±âÇÐȸ Á¦52Â÷ Ãß°èÇмú´ëȸ ¿ì¼ö½É»çÀ§¿ø»ó ¼ö»ó (2008)
  • ´ëÇѼøÈ¯±âÇÐȸ Á¦ 1ȸ ÀþÀº¿¬±¸ÀÚ»ó ¼ö»ó (1995)

ÇÐȸȰµ¿

Academic activities
  • ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ºñ»óÀÓÀÌ»ç
  • Çѱ¹ÁöÁú¡¤µ¿¸Æ°æÈ­ÇÐȸ ÆòÀÇ¿ø
  • ´ëÇѽÉÀåÇÐȸÁö(KJC) ³í¹®½É»çÀ§¿ø
  • ´ëÇѽÉÀåÇÐȸ ±âÃʰúÇבּ¸È¸ ¿î¿µÀ§¿ø
±¸Á¶½ÉÁúȯ ¸Å´º¾ó
´ëÇ¥¼­Àû

±¸Á¶½ÉÁúȯ ¸Å´º¾ó

  • ÀúÀÚ(±Û)±¸Á¶½ÉÁúȯ¿¬±¸È¸
  • ÃâÆÇ»ç¸ÞµðÄÿ¡µàÄÉÀ̼Ç
  • ¹ßÇàÀÏ2020³â
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 3°Ç
Á¦ ¸ñ ½ÉÀåÀçȰÀ» À§ÇÑ ¿îµ¿°ú »ýȰ¿ä¹ý
ÃâÆÇ»ç °í·Á´ëÇб³ÃâÆÇºÎ ¹ßÇàÀÏ 2013³â
Á¦ ¸ñ 3î¸(Àú) ¹ä»ó
ÃâÆÇ»ç ±×¸®°íÃ¥ ¹ßÇàÀÏ 2013³â
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 5°Ç
Á¦ ¸ñ [SCI]Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients
¹ßÇ¥³âµµ 2020. 03 ¹ßÇ¥Áö CIRCULATION-CARDIOVASCULAR INTERVENTIONS
Á¦ ¸ñ [SCI]Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention with Current-Generation Drug-Eluting Stent
¹ßÇ¥³âµµ 2020. 02 ¹ßÇ¥Áö CIRCULATION: CARDIOVASCULAR INTERVENTIONS
Á¦ ¸ñ [SCI]A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions
¹ßÇ¥³âµµ 2020. 02 ¹ßÇ¥Áö BMC CARDIOVASCULAR DISORDERS
Á¦ ¸ñ [SCI]Modulating cardiomyocyte and fibroblast interaction using layer-by-layer deposition facilitates synchronisation of cardiac macro tissues
¹ßÇ¥³âµµ 2020. 01 ¹ßÇ¥Áö SOFT MATTER
Á¦ ¸ñ [SCI]Cardioprotective effects of genetically engineered cardiac stem cells by spheroid formation on ischemic cardiomyocytes
¹ßÇ¥³âµµ 2020. 01 ¹ßÇ¥Áö MOLECULAR MEDICINE

¸íÀÇqna ¸íÀÇ QnA

Q °¡Àå °ü½É ÀÖ´Â ºÐ¾ß¿Í ¾÷ÀûÀÌ ÀÖ´Ù¸é ¾Ë·ÁÁÖ¼¼¿ä

½É±Ù°æ»öÁõ Àç»ý
´ëÇѹα¹ ÀÇÇÐÇѸ²¿ø Á¤È¸¿ø
¼­¿ï½Ã ´ë»çÁõÈıº Áö¿ø»ç¾÷´Ü´ÜÀå

Q ȯÀÚ Áø·á¿¡ ÀÖ¾î °¡Àå Áß¿äÇÏ°Ô »ý°¢ÇÏ´Â °¡Ä¡´Â?

°¡Àå Áß¿äÇÏ°Ô »ý°¢ÇÏ´Â °¡Ä¡´Â ȯÀÚÀÇ ¾ÈÀü°ú °Ç°­À» ¿ì¼±À¸·Î ÇÏ´Â °ÍÀÔ´Ï´Ù. ȯÀÚ¸¶´Ù °³º°ÀûÀ¸·Î ÀǰßÀ» Á¸ÁßÇϰí Á¤È®ÇÑ Áø´ÜÀ» ³»·Á¼­ ÃÖ»óÀÇ Ä¡·á °á°ú¸¦ À̲ø¾î³»·Á°í ÇÕ´Ï´Ù.

Q ȯÀڵ鿡°Ô ÀüÇÏ°í ½ÍÀº ¸»¾¸

°Ç°­À» ÀÒÀ¸¸é ¸ðµç °ÍÀ» ÀÒ´Â °Í°ú °°´Ù°í ÇÕ´Ï´Ù. ±×·¯ÇÏ¿© ´Ê±âÀü¿¡ Á¤±âÀûÀÎ °ËÁøÀ» ÅëÇÏ¿© ÁÖ±âÀûÀ¸·Î »óŸ¦ üũÇϰí, °Ç°­ÇÑ ½Ä½À°ü ¹× ¿îµ¿ µî °Ç°­ÇÑ »ýȰ½À°üÀ» °¡Áö´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù.

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°í·Á´ëÇб³ ¾È¾Ïº´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1577-0083
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°í·Á´ëÇб³ ¾È¾Ïº´¿øÀº 1056º´»ó ±Ô¸ð¸¦ °®Ãá »ó±ÞÁ¾ÇÕº´¿øÀ¸·Î¼­ ÁßÁõ ¹× ±Þ¼º±â ÁúȯÀ» Áß½ÉÀ¸·Î ´Ù¾çÇÑ Æ¯¼ºÈ­¼¾Å͸¦ ¿î¿µÇϰí ÀÖ´Ù. º´¿ø Àü¹Ý¿¡ ½º¸¶Æ® ÇコÄÉ¾î ½Ã½ºÅÛÀ» µµÀÔÇØ º¸´Ù Á¤È®ÇÏ°í ¾ÈÀüÇÑ ÀÇ·á¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖÀ¸¸ç, ±¹°¡ÁöÁ¤ ¿¬±¸Á߽ɺ´¿øÀ¸·Î ¿¬¼Ó ÁöÁ¤µÇ´Â µî ¿¬±¸ ¿ª·®ÀÇ ¿ì¼ö¼ºÀ» ÀÎÁ¤¹Þ°í ÀÖ´Ù.

°í·Á´ëÇб³ ¾È¾Ïº´¿ø À̹ÌÁö

¼­¿ïƯº°½Ã ¼ººÏ±¸ °í·Á´ë·Î 73 °í·Á´ëÇб³ ¾È¾Ïº´¿ø

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä